Expression and characterization of androgen receptor coregulators, SRC-2 and HBO1, during human testis ontogenesis and in androgen signaling deficient patients

Molecular and Cellular Endocrinology

Volumn 375, Issue 1-2, 2013, Pages 140-148

  Vija, Lavinia ^a,b,c   Meduri, Geri ^b   Comperat, Eva ^d   Vasiliu, Viorel ^e   Izard, Vincent ^f   Ferlicot, Sophie ^a   Boukari, Kahina ^b   Camparo, Philippe ^g   Viengchareun, Say ^a,b   Constancis, Elisabeth ^h   Dumitrache, Constantin ^c   Lombès, Marc ^a,b,f   Young, Jacques ^a,b,f  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSERM   (France)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f BICÊTRE HOSPITAL   (France)

^g Centre de pathologie   (France)

^h CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Androgen receptor; Human testicular ontogenesis; Nuclear receptor coregulators

Indexed keywords

ANDROGEN RECEPTOR; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE BINDING TO ORIGIN RECOGNITION COMPLEX; NUCLEAR RECEPTOR COACTIVATOR 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ADULTHOOD; ANDROGEN INSENSITIVITY SYNDROME; ANIMAL CELL; ARTICLE; CHILD; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FETUS; GENETIC TRANSFECTION; GERM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANCY; INFANT; MALE; MOUSE; NEWBORN; NONHUMAN; ONTOGENY; PERINATAL PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SERTOLI CELL; SIGNAL TRANSDUCTION; TESTIS DEVELOPMENT;

ADOLESCENT; ADULT; ANDROGEN-INSENSITIVITY SYNDROME; ANDROGENS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DIHYDROTESTOSTERONE; ENZYME INDUCTION; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONE ACETYLTRANSFERASES; HUMANS; INFANT; MALE; MIDDLE AGED; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN TRANSPORT; RECEPTORS, ANDROGEN; SEMINIFEROUS TUBULES; SIGNAL TRANSDUCTION; SPERMATOGENESIS; YOUNG ADULT;

EID: 84879456053     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.05.004     Document Type: Article

References (48)

1. Avvakumov N., Lalonde M.E., Saksouk N., Paquet E., Glass K.C., Landry A.J., Doyon Y., Cayrou C., Robitaille G.A., Richard D.E., Yang X.J., Kutateladze T.G., Cote J. Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation. Mol. Cell Biol. 2012, 32:689-703.
2. Awasthi S., Simons S.S. Separate regions of glucocorticoid receptor, coactivator TIF2, and comodulator STAMP modify different parameters of glucocorticoid-mediated gene induction. Mol. Cell Endocrinol. 2012, 355:121-134.
3. Bar-Shira Maymon B., Yogev L., Yavetz H., Lifschitz-Mercer B., Schreiber L., Kleiman S.E., Botchan A., Hauser R., Paz G. Spermatogonial proliferation patterns in men with azoospermia of different etiologies. Fertil. Steril. 2003, 80:1175-1180.
4. Boukari K., Ciampi M.L., Guiochon-Mantel A., Young J., Lombes M., Meduri G. Human fetal testis: source of estrogen and target of estrogen action. Hum. Reprod. 2007, 22:1885-1892.
5. Boukari K., Meduri G., Brailly-Tabard S., Guibourdenche J., Ciampi M.L., Massin N., Martinerie L., Picard J.Y., Rey R., Lombes M., Young J. Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. J. Clin. Endocrinol. Metab. 2009, 94:1818-1825.
6. Brinkmann A.O. Molecular mechanisms of androgen action-a historical perspective. Methods Mol. Biol. 2011, 776:3-24.
7. Cavaco J.E., Laurentino S.S., Barros A., Sousa M., Socorro S. Estrogen receptors alpha and beta in human testis: both isoforms are expressed. Syst. Biol. Reprod. Med. 2009, 55:137-144.
8. Chemes H.E., Rey R.A., Nistal M., Regadera J., Musse M., Gonzalez-Peramato P., Serrano A. Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. J. Clin. Endocrinol. Metab. 2008, 93:4408-4412.
9. Coviello A.D., Matsumoto A.M., Bremner W.J., Herbst K.L., Amory J.K., Anawalt B.D., Sutton P.R., Wright W.W., Brown T.R., Yan X., Zirkin B.R., Jarow J.P. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J. Clin. Endocrinol. Metab. 2005, 90:2595-2602.
10. Dutertre M., Rey R., Porteu A., Josso N., Picard J.Y. A mouse Sertoli cell line expressing anti-Mullerian hormone and its type II receptor. Mol. Cell Endocrinol. 1997, 136:57-65.
11. Ferlin A., Vinanzi C., Garolla A., Selice R., Zuccarello D., Cazzadore C., Foresta C. Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations. Clin. Endocrinol. (Oxf). 2006, 65:606-610.
12. Gehin M., Mark M., Dennefeld C., Dierich A., Gronemeyer H., Chambon P. The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol. Cell Biol. 2002, 22:5923-5937.
13. Georgiakaki M., Chabbert-Buffet N., Dasen B., Meduri G., Wenk S., Rajhi L., Amazit L., Chauchereau A., Burger C.W., Blok L.J., Milgrom E., Lombes M., Guiochon-Mantel A., Loosfelt H. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription. Mol. Endocrinol. 2006, 20:2122-2140.
14. Ghadessy F.J., Lim J., Abdullah A.A., Panet-Raymond V., Choo C.K., Lumbroso R., Tut T.G., Gottlieb B., Pinsky L., Trifiro M.A., Yong E.L. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions. J. Clin. Invest. 1999, 103:1517-1525.
15. Gottlieb B., Lombroso R., Beitel L.K., Trifiro M.A. Molecular pathology of the androgen receptor in male (in)fertility. Reprod. Biomed. Online 2005, 10:42-48.
16. Han Y., Feng H.L., Sandlow J.I., Haines C.J. Comparing expression of progesterone and estrogen receptors in testicular tissue from men with obstructive and nonobstructive azoospermia. J. Androl. 2009, 30:127-133.
17. Heemers H.V., Tindall D.J. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr. Rev. 2007, 28:778-808.
18. Heinlein C.A., Chang C. Androgen receptor (AR) coregulators: an overview. Endocr. Rev. 2002, 23:175-200.
19. Hiort O., Sinnecker G.H., Holterhus P.M., Nitsche E.M., Kruse K. The clinical and molecular spectrum of androgen insensitivity syndromes. Am. J. Med. Genet. 1996, 63:218-222.
20. Hiort O., Holterhus P.M., Horter T., Schulze W., Kremke B., Bals-Pratsch M., Sinnecker G.H., Kruse K. Significance of mutations in the androgen receptor gene in males with idiopathic infertility. J. Clin. Endocrinol. Metab. 2000, 85:2810-2815.
21. Hofman K., Swinnen J.V., Verhoeven G., Heyns W. Coactivation of an endogenous progesterone receptor by TIF2 in COS-7 cells. Biochem. Biophys. Res. Commun. 2002, 295:469-474.
22. Iizuka M., Matsui T., Takisawa H., Smith M.M. Regulation of replication licensing by acetyltransferase Hbo1. Mol. Cell Biol. 2006, 26:1098-1108.
23. Jarow J.P., Zirkin B.R. The androgen microenvironment of the human testis and hormonal control of spermatogenesis. Ann. NY Acad. Sci. 2005, 1061:208-220.
24. Kelnar C.J., McKinnell C., Walker M., Morris K.D., Wallace W.H., Saunders P.T., Fraser H.M., Sharpe R.M. Testicular changes during infantile 'quiescence' in the marmoset and their gonadotrophin dependence: a model for investigating susceptibility of the prepubertal human testis to cancer therapy?. Hum. Reprod. 2002, 17:1367-1378.
25. Lan K.C., Hseh C.Y., Lu S.Y., Chang S.Y., Shyr C.R., Chen Y.T., Kang H.Y., Huang K.E. Expression of androgen receptor co-regulators in the testes of men with azoospermia. Fertil. Steril. 2008, 89:1397-1405.
26. Lim J., Ghadessy F.J., Abdullah A.A., Pinsky L., Trifiro M., Yong E.L. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2). Mol. Endocrinol. 2000, 14:1187-1197.
27. Lonard D.M., O'Malley B.W. Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nat. Rev. Endocrinol. 2012.
28. Luetjens C.M., Didolkar A., Kliesch S., Paulus W., Jeibmann A., Bocker W., Nieschlag E., Simoni M. Tissue expression of the nuclear progesterone receptor in male non-human primates and men. J. Endocrinol. 2006, 189:529-539.
29. Massin N., Bry H., Vija L., Maione L., Constancis E., Haddad B., Morel Y., Claessens F., Young J. Healthy birth after testicular extraction of sperm and ICSI from an azoospermic man with mild androgen insensitivity syndrome caused by an androgen receptor partial loss-of-function mutation. Clin. Endocrinol. (Oxf.) 2012, 77:593-598.
30. Nistal M., Abaurrea M.A., Paniagua R. Morphological and histometric study on the human Sertoli cell from birth to the onset of puberty. J. Anat. 1982, 134:351-363.
31. Pais V., Leav I., Lau K.M., Jiang Z., Ho S.M. Estrogen receptor-beta expression in human testicular germ cell tumors. Clin. Cancer Res. 2003, 9:4475-4482.
32. Quigley C.A., Tan J.A., He B., Zhou Z.X., Mebarki F., Morel Y., Forest M.G., Chatelain P., Ritzen E.M., French F.S., Wilson E.M. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction. Mech. Age. Dev. 2004, 125:683-695.
33. Regadera J. Androgen insensitivity syndrome: an immunohistochemical, ultrastructural, and morphometric study. Arch. Pathol. Lab. Med. 1999, 123:225-234.
34. Rey R.A., Musse M., Venara M., Chemes H.E. Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on Sertoli cell maturation and the onset of adult spermatogenesis. Microsc. Res. Tech. 2009, 72:787-795.
35. Rogatsch H., Jezek D., Hittmair A., Mikuz G., Feichtinger H. Expression of vimentin, cytokeratin, and desmin in Sertoli cells of human fetal, cryptorchid, and tumour-adjacent testicular tissue. Virchows Arch. 1996, 427:497-502.
36. Schaison G., Young J., Pholsena M., Nahoul K., Couzinet B. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 1993, 77:1545-1549.
37. Shah C., Modi D., Sachdeva G., Gadkar S., Puri C. Coexistence of intracellular and membrane-bound progesterone receptors in human testis. J. Clin. Endocrinol. Metab. 2005, 90:474-483.
38. Sharma M., Zarnegar M., Li X., Lim B., Sun Z. Androgen receptor interacts with a novel MYST protein, HBO1. J. Biol. Chem. 2000, 275:35200-35208.
39. Steger K., Aleithe I., Behre H., Bergmann M. The proliferation of spermatogonia in normal and pathological human seminiferous epithelium: an immunohistochemical study using monoclonal antibodies against Ki-67 protein and proliferating cell nuclear antigen. Mol. Hum. Reprod. 1998, 4:227-233.
40. Suarez-Quian C.A., Martinez-Garcia F., Nistal M., Regadera J. Androgen receptor distribution in adult human testis. J. Clin. Endocrinol. Metab. 1999, 84:350-358.
41. Takagi S., Itoh N., Kimura M., Sasao T., Tsukamoto T. Spermatogonial proliferation and apoptosis in hypospermatogenesis associated with nonobstructive azoospermia. Fertil. Steril. 2001, 76:901-907.
42. Tan J., Hall S.H., Hamil K.G., Grossman G., Petrusz P., Liao J., Shuai K., French F.S. Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis. Mol. Endocrinol. 2000, 14:14-26.
43. van de Wijngaart D.J., Dubbink H.J., van Royen M.E., Trapman J., Jenster G. Androgen receptor coregulators: recruitment via the coactivator binding groove. Mol. Cell Endocrinol. 2012, 352:57-69.
44. Warnmark A., Almlof T., Leers J., Gustafsson J.A., Treuter E. Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta. J. Biol. Chem. 2001, 276:23397-23404.
45. Warnmark A., Treuter E., Gustafsson J.A., Hubbard R.E., Brzozowski A.M., Pike A.C. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha. J. Biol. Chem. 2002, 277:21862-21868.
46. Ye X., Han S.J., Tsai S.Y., DeMayo F.J., Xu J., Tsai M.J., O'Malley B.W. Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice. Proc. Natl. Acad. Sci. USA 2005, 102:9487-9492.
47. Yong E.L., Loy C.J., Sim K.S. Androgen receptor gene and male infertility. Hum. Reprod. Update 2003, 9:1-7.
48. Young J. Approach to the male patient with congenital hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 2012, 97:707-718.